Drug
Minodronic Acid
Minodronic Acid: highest development phase Phase 3, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Minodronic acid hydrate NCT00212628 | Phase 3 | Involutional Osteoporosis |
Latest
No recent events.
Follow Minodronic Acid on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.